Central Laboratories Applications & Studies
-
RWD's Significance In The Largest FDA-Funded IOL Study Of Pediatric Patients
5/28/2025
With FDA grant support, the American Academy of Ophthalmology and Verana Health conducted the largest real-world study to date on intraocular lens (IOL) use in pediatric cataract patients.
-
Understanding Real-World Patient Characterization And Safety Outcomes Of DEXTENZA
5/8/2025
In this study, we can derive confirmation of DEXTENZA’s favorable safety profile across a broader surgical spectrum.
-
Streamlining Patient Recruitment With AIāDriven Site Identification
5/1/2025
This study highlights the use of an RWD-driven, AI-enabled recruitment models as a transformative strategy for clinical development in hard-to-recruit populations.
-
Feasibility Insights In HR+/HER2 - Metastatic Breast Cancer
4/16/2025
This case study showcases how advanced analytics were used to streamline feasibility planning for a Phase II clinical trial targeting HR+/HER2- metastatic breast cancer as a second-line treatment.
-
Timely Lab Data To Inform Outreach To Healthcare Professionals
4/3/2025
Learn how you can leverage a system that offers flexible data delivery formats and seamless integration into commercialization workflows while also ensuring HIPAA-compliant deidentified data for patient privacy.
-
6 Key Ways Real-World Data Is Accelerating Breast Cancer Therapies
2/3/2025
Real-world data (RWD) is increasingly vital for advancing breast cancer research, and leveraging TA datasets allows researchers and clinicians to address pressing challenges.
-
8 Key Applications Of Real-World Data In Multiple Myeloma Therapy Development
2/3/2025
Explore how therapeutic area (TA) datasets can be leveraged to address the challenges multiple myeloma (MM) presents in the field of hematologic malignancies.
-
Data-Driven Physician Engagement For Ultra-Rare Diseases
2/3/2025
How can an effective partnership help you to utilize advanced data analytics to address the significant challenges of clinical trials centered around ultra-rare diseases?
-
How eSource Reduced Benchmark's Protocol Deviations By Almost 40%
1/6/2025
Explore how a leading vaccine site network selected CRIO to help address the challenges with it's use of paper charts in collecting source data.
-
Defining And Implementing Global Data Standards & Governance
10/28/2024
Discover how implementing global data standards and governance for a biopharma company, creates unified data management, standardized terminology, and a central ontology to enhance R&D efficiency.